Novartis Investigative Site
Northeim 37154
0 studies enrolling now · 4 studies all time
What they study most
Atherosclerosis, Cardiovascular Disease and Lipoprotein(a), Chronic Heart Failure, Heart Failure With Preserved Ejection Fraction
Studies at this site
- Lipoprotein(a) in Patients With Cardiovascular Disease (CVD) — Completed
- Efficacy and Safety of LCZ696 Compared to Valsartan, on Morbidity and Mortality in Heart Failure Patients With Preserved Ejection Fraction — Completed
- Cardiovascular Risk Reduction Study (Reduction in Recurrent Major CV Disease Events) — Completed
- Efficacy and Safety of Aliskiren and Aliskiren/Enalapril Combination on Morbidity-mortality in Patients With Chronic Heart Failure — Completed